<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02480972</url>
  </required_header>
  <id_info>
    <org_study_id>SNUH-082-618</org_study_id>
    <nct_id>NCT02480972</nct_id>
  </id_info>
  <brief_title>Hepatic Fibrosis Assessment Using Multiparametric Magnetic Resonance Imaging</brief_title>
  <official_title>Hepatic Fibrosis Assessment Using Multiparametric Magnetic Resonance Imaging (MRI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Research Foundation of Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess degree of hepatic fibrosis using multiparametric MRI
      for investigating difference between normal or early fibrosis and advanced fibrosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In patients with liver parenchymal disease or normal liver parenchyma who are scheduled to
      undergo either liver resection or liver biopsy are included.

      Referred patients undergo multiparametric MRI including perfusion, diffusion, elastography
      and fat quantification before surgery or biopsy.

      The pathophysiologic changes are evaluated using multiparametric MRI, and compared between
      normal/early fibrosis and advanced fibrosis.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>difference of portal flow between no or early hepatic fibrosis and advanced hepatic fibrosis</measure>
    <time_frame>in three years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>difference of arterial flow between no or early hepatic fibrosis and advanced hepatic fibrosis</measure>
    <time_frame>in three years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>difference of liver stiffness value between no or early hepatic fibrosis and advanced fibrosis</measure>
    <time_frame>in three years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>monitoring of transient dyspnea after contrast media injection</measure>
    <time_frame>in three years</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">69</enrollment>
  <condition>Fibrosis</condition>
  <condition>Cirrhosis</condition>
  <arm_group>
    <arm_group_label>Magnetic resonance imaging</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>multiparametric MRI including perfusion, diffusion, MR fat quantification and MR elastography</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>magnetic resonance imaging</intervention_name>
    <description>multiparametric MRI as follows:
diffusion weighted imaging using multiple b-values
Fat quantification sequence
perfusion MRI using ECCM agent
MR elastography
routine MRI using hepatocyte specific agent (optional in patients with focal liver lesion)</description>
    <arm_group_label>Magnetic resonance imaging</arm_group_label>
    <other_name>MRI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who are scheduled to undergo liver resection for focal liver lesion

          -  patients who are scheduled to undergo liver resection or percutaneous biopsy for
             diffuse parenchymal disease

          -  liver donor candidate who are scheduled to undergo preoperative liver biopsy or liver
             resection

          -  AND patients/living donor candidates who sign informed consent

        Exclusion Criteria: Patients who have at least one of followings are excluded.

          -  Patients who are contraindication for MRI contrast enhanced MRI.

          -  Premenopausal female patients who are pregnant.

          -  Patients who are physically compromised to acquire liver MRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeong Min Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2015</study_first_submitted>
  <study_first_submitted_qc>June 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2015</study_first_posted>
  <last_update_submitted>March 22, 2018</last_update_submitted>
  <last_update_submitted_qc>March 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jeong Min Lee</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>fibrosis</keyword>
  <keyword>cirrhosis</keyword>
  <keyword>MRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

